Petra Kirchhoff - Sartorius Aktiengesellscha President

SARTF Stock  USD 182.98  9.77  5.07%   

President

Ms. Petra Kirchhoff was Independent Member of the Supervisory Board of Sartorius Aktiengesellschaft since October 1, 2010. She is Head of Corporationrationrate Communications and Investor Relations at Sartorius Corporationrationrate Administration GmbH in Goettingen, Germany. She serves on the Supervisory Board of AWO Goettingen GmbH and on the Foundation Board of Directors of SuedniedersachsenStiftung, among others. She is a graduate in political economy. since 2010.
Age 54
Tenure 14 years
Phone49 551 308 0
Webhttps://www.sartorius.com

Sartorius Aktiengesellscha Management Efficiency

The company has return on total asset (ROA) of 0.106 % which means that it generated a profit of $0.106 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3386 %, meaning that it generated $0.3386 on every $100 dollars invested by stockholders. Sartorius Aktiengesellscha's management efficiency ratios could be used to measure how well Sartorius Aktiengesellscha manages its routine affairs as well as how well it operates its assets and liabilities.
Sartorius Aktiengesellschaft has accumulated 1.65 B in total debt with debt to equity ratio (D/E) of 1.03, which is about average as compared to similar companies. Sartorius Aktiengesellscha has a current ratio of 0.94, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Sartorius Aktiengesellscha until it has trouble settling it off, either with new capital or with free cash flow. So, Sartorius Aktiengesellscha's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Sartorius Aktiengesellscha sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Sartorius to invest in growth at high rates of return. When we think about Sartorius Aktiengesellscha's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

PRESIDENT Age

Andy PolywaczWest Pharmaceutical Services
N/A
Christopher RyanWest Pharmaceutical Services
63
Ralf KuriyelRepligen
66
Bobby GhoshalResMed Inc
52
Philippe SubrinSTAAR Surgical
60
Raj SodhiResMed Inc
45
David MontecalvoWest Pharmaceutical Services
54
Silji AbrahamWest Pharmaceutical Services
52
Chad WintersWest Pharmaceutical Services
45
Jim HollingsheadResMed Inc
57
George MillerWest Pharmaceutical Services
64
Daniel WoolsonICU Medical
47
Don OCallaghanWest Pharmaceutical Services
N/A
Quintin LaiWest Pharmaceutical Services
53
Samuel GestenSTAAR Surgical
62
Olivier LoeillotRepligen
54
Virginia SanzoneICU Medical
49
Bernard BirkettWest Pharmaceutical Services
55
HansMartin BlickensdoerferSTAAR Surgical
59
Keith HollidaySTAAR Surgical
61
Aileen RuffPatryWest Pharmaceutical Services
N/A
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company was founded in 1870 and is headquartered in Gttingen, Germany. Sartorius operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 13832 people. Sartorius Aktiengesellschaft [SARTF] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Sartorius Aktiengesellscha Leadership Team

Elected by the shareholders, the Sartorius Aktiengesellscha's board of directors comprises two types of representatives: Sartorius Aktiengesellscha inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sartorius. The board's role is to monitor Sartorius Aktiengesellscha's management team and ensure that shareholders' interests are well served. Sartorius Aktiengesellscha's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sartorius Aktiengesellscha's outside directors are responsible for providing unbiased perspectives on the board's policies.
Rene Faber, Member of the Executive Board, Head of the Bioprocess Solutions Division
Petra Kirchhoff, Member of the Supervisory Board, Vice President of Corporate Communications & Investor Relations
Rashid Maqbool, Head USA
Manfred Werner, Sr Auditing
John MacKay, Member of the Executive Board, Head of the Lab Products & Services Division
Patricia Spannagel, Head Goettingen
Mei Wang, Head China
Joachim Kreuzburg, Chairman of the Executive Board, CEO, Executive for Labor Relations
Rainer Lehmann, CFO, Member of the Executive Board
Manohar Kuppusami, Head India

Sartorius Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Sartorius Aktiengesellscha a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Other Information on Investing in Sartorius Pink Sheet

Sartorius Aktiengesellscha financial ratios help investors to determine whether Sartorius Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sartorius with respect to the benefits of owning Sartorius Aktiengesellscha security.